|
Human Gene Therapy
Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography
To cite this article:
John O. Konz, Rebecca C. Livingood, Andrew J. Bett, Aaron R. Goerke, Michael E. Laska, Sangeetha L. Sagar.
Human Gene Therapy.
November 2005,
16(11): 1346-1353.
doi:10.1089/hum.2005.16.1346.
Dr. John O. Konz Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486. Rebecca C. Livingood Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486. Andrew J. Bett Vaccine and Biologics Research, Merck Research Laboratories, West Point, PA 19486. Aaron R. Goerke Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486. Michael E. Laska Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486. Sangeetha L. Sagar Biologics Development and Engineering, Merck Research Laboratories, West Point, PA 19486. Recombinant adenoviruses continue to be a leading vector choice for gene transfer applications, with growing interest in the use of less prevalent serotypes, and of chimeras. As a result, the development of scaleable purification processes for alternative serotypes is needed. Anion-exchange chromatography is routinely used for scaleable adenovirus type 5 purification; however, retention varies for other serotypes because of differences in the exposed capsid proteins. Understanding how the viral surface influences retention behavior can provide a rational basis for chromatography development and optimization. In this work, chimeric vectors were used to show that the hexon protein is responsible for retention differences in anion-exchange chromatography. Next, the relative retention of eight serotypes from three subgroups was studied. Although all serotypes bound to the anion-exchange resin, the sodium chloride required to elute the virus varied over a 2- fold range, from 270 to 490 mM. Retention was accurately correlated to the electrostatic properties of the hexon protein, with an average error in sodium chloride concentration required to elute of only 14 mM. This correlation enables preparative chromatography gradients for alternative serotypes to be established with minimal effort.  This paper was cited by:Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics Daniel M. Strauss, Scott Lute, Zinaida Tebaykina, Douglas D. Frey, Cintia Ho, Gregory S. Blank, Kurt Brorson, Qi Chen, Bin Yang Biotechnology and Bioengineering. Feb 2009: n/a-n/a CrossRef Flow-dependent entrapment of large bioparticles in porous process media Egor I. Trilisky, Abraham M. Lenhoff Biotechnology and Bioengineering. Feb 2009: n/a-n/a CrossRef Anion exchange chromatography provides a robust, predictable process to ensure viral safety of biotechnology products Daniel M. Strauss, Jeffrey Gorrell, Magdalena Plancarte, Gregory S. Blank, Qi Chen, Bin Yang Biotechnology and Bioengineering. Feb 2009, Vol. 102, No. 1: 168-175 CrossRef Towards purification of adenoviral vectors based on membrane technology Cristina Peixoto, Tiago B. Ferreira, Marcos F. Q. Sousa, Manuel J. T. Carrondo, Paula M. Alves Biotechnology Progress. Dec 2008, Vol. 24, No. 6: 1290-1296 CrossRef
|
|